Starkey Donates 80,000 Masks to Healthcare Workers
EDEN PRAIRIE, MINNESOTA – As part of its ongoing efforts to support hearing and healthcare providers during the COVID-19 pandemic, this week, Starkey donated more than 80,000 masks to Hennepin County in Minnesota. The donation is in response to the shortage of personal protective equipment in hospitals across the country. “We are grateful to the healthcare…
Read More
Decibel Therapeutics Publishes Encouraging Results from Phase 1a Clinical Trial of DB-020
BOSTON, MASSACHUSSETTS — Decibel Therapeutics, a development-stage biotechnology company developing novel regenerative therapeutics for hearing loss and balance disorders, announced that Phase 1a trial results demonstrating the safety and tolerability of its lead candidate, DB-020, have been published in the peer-reviewed journal Investigational New Drugs. DB-020 is being developed for the prevention of cisplatin-induced hearing…
Read More
Cochlear Announces Launch of $850M Equity Raising
Hearing implant maker, Cochlear, has announced today that the company will be undergoing capital raising efforts to ensure the company “remains strong during and after the COVID-19 pandemic.” The company looks to raise over $500M USD ($850M AUS). The company, which had reduced its profit forecast in early February due to the impact of the…
Read More
Hearing Industries Association Issues Statement Regarding Hearing Health During the COVID-19 Pandemic
WASHINGTON, DC — The Hearing Industries Association (HIA) leadership has issued a statement regarding hearing healthcare in the United States during the COVID-19 pandemic. The full text of the statement can be read below: ______________________________________ The hearing healthcare industry, like many businesses in the United States and around the world, is facing an unprecedented challenge. As…
Read More
AAA Executive Committee Advises Clinics to Close Doors, Practice Telehealth, to Reduce Spread of COVID-19 Virus
RESTON, VIRGINIA — The American Academy of Audiology (AAA) Executive Committee issued a statement to its members and fellow audiologists this morning, reflecting the growing seriousness of the COVID-19 pandemic that is spreading rapidly around the globe. The statement, entitled “Work Together, Stay Informed, and Help Flatten the Curve”, can be read in its entirety…
Read More
Earlens, Eargo and GN Hearing Named 2020 Edison Award Winners
NEW YORK, NEW YORK — Earlens, Eargo and GN Hearing have been named among this year’s Edison Awards winners in the category of ‘Hearing Technology’. Being recognized with an Edison Award considered “one of the highest accolades a company can receive for the successful launch of a ‘game-changing’ new product or service”. The diverse groups…
Read More
Cochlear Receives FDA Approval to Lower Age of Cochlear Implantation to 9 months
CENTENNIAL, COLORADO — Cochlear Limited, the global leader in implantable hearing solutions, announced that it has obtained U.S. Food and Drug Administration (FDA) approval to lower the age of cochlear implantation from 12 months to 9 months for children with bilateral, profound sensorineural hearing loss. This approval “ensures children born deaf have earlier access to a…
Read More
Ida Institute Offers Professionals New Learning Hall Course on the Six Elements of Person-Centered Care
NAERUM, DENMARK — Person-centered care is multi-faceted, and becoming a proficient, person-centered hearing care practitioner requires considering a client’s needs from different angles. The Ida Institute’s new Learning Hall course, “Understanding the Elements of PCC,” provides a comprehensive overview of the different factors in a person-centered approach over six short modules. The modules are “composed…
Read More
Coronavirus Outbreak Contributes to Delays in Sensorion’s Sudden Hearing Loss Phase II Clinical Trial
MONTPELLIER, FRANCE — Sensorion, a clinical-stage biotech company specializing in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced updated timelines for the ongoing Phase 2 study of SENS-401 to treat Sudden Sensorineural Hearing Loss (SSNHL). Patient recruitment rates from this trial now indicate the…
Read More
Audiology Australia Announces 2020 Conference Postponed
PERTH, AUSTRALIA — Audiology Australia announced today that its planned 2020 conference will be postponed until later in the year. This year’s conference was originally planned for May 3-6 and included several well-known keynote speakers. The news comes just days following the American Academy of Audiology’s decision to cancel its planned 2020 conference. Audiology Australia…
Read More